Cancer and COVID-19; how do we manage cancer optimally through a public health crisis?
Cet article croate présente les enjeux liés à la prise en charge des patients atteints d’un cancer pendant la crise sanitaire liée au COVID-19
The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far infected nearly one million people worldwide, with over 40,000 deaths (1). Epidemiological projections of likely numbers of people who will be infected and die, based on our short experience with this virus, show a significant impact in those above 65 years with comorbidities, but especially in the 80+ group. In an attempt to both reduce COVID-19 related deaths but mostly to ‘flatten the curve’ i.e